Touyun Biotech 01332Prospectus Information

Prospectus & Stock Connect
Data layers Raw facts Calculated Model prediction AI interpretation
Company Overview
Stock NameTouyun Biotech
Stock Code01332
Company Full NameTo be extracted
Industry工用支援
Principal Activities主要從事生產及銷售包裝產品;提供產品包裝上的二維碼及解決方案以及廣告展示服務;生產及銷售萊茵衣藻、微藻及相關產品;證券投資及買賣、放貸、證券經紀及保證金融資。
Listing Date2012-07-12
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)香港灣仔杜老志道6號群策大廈12樓
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttp://www.touyunbiotech.com.hk
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo data
Offering Information
Offering Mechanism To be extracted
Offer PriceHK$ 1.59 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)—
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 9,142,500
Stock Connect Inclusion
HK Market Cap ---
26Q2 Regular Review
Inclusion Pathway None
Est. Threshold ---
Analysis Result 无法确定入通路径
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 1.42
First Day OpenHK$ 1.68
First Day Change-10.69%
First Day Volume17094300.0
First Day Turnover24596500.0
Use of Proceeds
Use of Proceeds1、約40%將動用作購買及更換機械及設備,以提升本集團的生產效能及能力,據此新購機械及設備預期將使年產能增加約十分之一; 2、約40%將會動用作開拓新業務機會及提高本集團所生產的產品于市場上的知名度; 3、約10%將會動用作提升本集團設計及開發本集團所生產產品的能力,當中包括購置新型計算機硬件及軟件; 4、約10%將會動用作一般營運資金及其他一般企業用途。
Underwriting Syndicate
Sole Sponsor (1)
HAITONG INTERNATIONAL CAPITAL LIMITED CE ADQ859
Joint Lead Managers (1)
HAITONG INTERNATIONAL SECURITIES COMPANY LIMITED CE AAF806
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
Chairman王亮
Company Secretary李安樂
No director data available.
Major Shareholders
Major Shareholders & Holdings王亮(22.24%);秦奮(7.04%);喬艷峰(5.35%);田宇澤(5.27%)
// About this page //

This page shows Touyun Biotech (01332) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements.

Disclaimer

Site Nature: This website (cibo.hk) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect